Breaking News - The Fly

Open Search

BPTH

Bio-Path

$

()

Bio-Path files to sell 484K shares of common stock for holders

BPTH

Today - 16:37pm

Bio-Path announces closing of $1.2M registered direct offering

BPTH

4/19/2024 - 12:18pm

Bio-Path announces $1.2M registered direct offering priced at-the-market

BPTH

4/18/2024 - 14:00pm

Bio-Path announces completion of higher dose second cohort in trial of BP1002

BPTH

4/18/2024 - 07:09am

Bio-Path expands global patent portfolio

BPTH

4/15/2024 - 07:04am

Bio-Path provides 2024 clinical, operational update

BPTH

4/2/2024 - 07:06am

Bio-Path price target raised by $28 at Roth MKM, here's why

BPTH

3/27/2024 - 08:05am

Bio-Path receives noncompliance letter from Nasdaq

BPTH

3/14/2024 - 09:24am

Bio-Path Holdings trading resumes

BPTH

3/12/2024 - 14:14pm

Bio-Path Holdings trading halted, volatility trading pause

BPTH

3/12/2024 - 14:09pm

Bio-Path files to sell 1.15M shares of common stock, warrants

BPTH

3/8/2024 - 17:16pm

Bio-Path reports FY23 EPS ($33.63) vs ($38.12) last year

BPTH

3/8/2024 - 07:02am

Bio-Path Holdings trading halted, news pending

BPTH

2/22/2024 - 19:50pm

Bio-Path announces 1-for-20 reverse stock split

BPTH

2/21/2024 - 07:11am

Bio-Path completes first dose escalation part of Phase 1 trial of BP1002

BPTH

1/10/2024 - 07:10am